"Procter & Gamble's Q2 FY2026 showed a business holding ground rather than accelerating, with organic sales flat and a 1% unit volume decline, while Beauty and Health Care led with 5% organic growth."
"Colgate's Q4 2025 reported a 5.8% revenue increase year-over-year, driven by a 2.2% organic sales growth and a significant contribution from Hill's Pet Nutrition, despite a 1.8% decline in North America."
"Procter & Gamble is restructuring at scale, targeting up to 7,000 non-manufacturing overhead cuts by FY2027, while absorbing approximately $400 million in after-tax tariff costs this fiscal year."
"Colgate's CEO Noel Wallace unveiled a 2030 strategy focused on AI-driven analytics and science-based innovation, aiming to enhance omni-channel demand generation despite facing a $919 million goodwill impairment."
Procter & Gamble reported flat organic sales with a decline in unit volume, while Colgate-Palmolive experienced a 5.8% revenue increase. Procter & Gamble's restructuring aims to cut overhead costs, facing tariff impacts and declining operating income. Colgate's strategy focuses on AI-driven analytics and innovation, despite a significant goodwill impairment affecting earnings. Both companies navigate similar market challenges but adopt different strategic approaches to growth and efficiency.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]